Against the Grain Pet Food Inc. voluntarily recalled certain 12 oz. cans of “Pulled Beef with Gravy Dinner for Dogs” on February 14, 2017
Pentobarbital is used as a sedative and euthanasia drug. The side effects include drowsiness, dizziness, excitement, nausea, loss of balance, eyes jerking back and forth, coma, and death.
The products were made in 2015 and distributed to stores in Maryland and Washington. While it is unlikely that consumers still have it in their homes, the official expiration-date is December 2019.
The recall involves Lot #2415E01ATB12. The second half of the UPC code is 80001 (which can be found on the back of the product label).
There have been no reports of dogs who got sick from this product, or any other product since Against the Grain was founded in 2012.
However, Food Safety News noticed that the same family owns Evanger’s Dog & Cat Food, which also recently recalled dog food due to pentobarbital contamination.
Five dogs got sick, including one dog who died, according to Evanger’s dog food recall issued on February 3, 2017.
Last month, a woman in Washington fed her four dogs Evanger’s “Hunk of Beef” on New Year’s Eve. Within 15 minutes, they were all sick. She told KATU:
They were falling over. So I grabbed them all and took them to the emergency vet. And when they got there, they were just limp. They weren’t moving or anything. And so they were in ICU. Tito and Talula ate the most and Talula passed away.”
Evanger’s said they are paying for her vet bills and “making a donation to a local shelter in honor of Talula the Pug.”
Evanger’s recalled certain 12 oz. “Hunk of Beef Au Jus” dog food cans that were sold in Washington, California, Minnesota, Illinois, Indiana, Michigan, Wisconsin, Ohio, Pennsylvania, New York, Massachusetts, Maryland, South Carolina, Georgia, and Florida.
The recalled dog food includs Lot #1816E03HB, #1816E04HB, #1816E06HB, #1816E07HB, and #1816E13HB, expiration date of June 2020. The second half of the barcode reads 20109.
Source: Against the Grain Pet Food recalls products over pentobarbital concerns